secwatch.observer — SEC 8-K summary
======================================

Issuer:     Candel Therapeutics, Inc. (CADL)
CIK:        0001841387
Form:       8-K
Filed at:   2025-12-05T23:59:59+00:00
Accession:  0001193125-25-308719
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Candel Therapeutics hosts virtual R&D Day with pipeline overview
----------------------------------------------------------------

- Virtual R&D Day held December 5, 2025, from 11:00 am to 1:45 pm ET.
- Presentation covers viral immunotherapy approach and oncology-focused pipeline.
- Presentation available on investor relations website at https://ir.candeltx.com.
- No specific clinical data or financial updates disclosed in the 8-K filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841387/000119312525308719/0001193125-25-308719-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841387/000119312525308719/d43361d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-308719

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer